Titration of the cell-associated virus (CAV) of varicella-zoster virus (VZV) is essential for antiviral studies. A VZV reporter cell line, MV9G, generated in our previous study expresses firefly luciferase upon CAV infection in a dose-dependent manner, suggesting that use of the cell line for titration is feasible. In this study, MeWo cells infected with VZV vaccine Oka (vOka) strain or with clinical isolates obtained from patients with varicella or zoster were used as CAV. A co-culture of MV9G cells with the virus-infected MeWo cells were set up and optimized for titration of CAV. Luciferase activities of MV9G cells measured as relative light units (RLUs) of chemiluminescence correlated well (r > 0.9, p < 0.05) both with quantities of viral DNAs measured by TaqMan PCR and with numbers of viral foci detected by immunostaining with a monoclonal antibody against VZV IE62. In addition, the usefulness of MV9G for antiviral studies was exemplified by treatment of the VZV-infected cells with various concentrations of acyclovir. Thus, the reporter cell-based titration of CAV by measuring the induced RLUs may be a reliable way to estimate viral foci and viral DNAs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jviromet.2018.06.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Optimizing CAR-NK Cell Transduction and Expansion: Leveraging Cytokine Modulation for Enhanced Performance.
Curr Protoc
November 2024
Université de Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 CANTHER, Lille, France.
Cellular immunotherapy has emerged as one of the most potent approaches to treating cancer patients. Adoptive transfer of chimeric antigen receptor (CAR) T cells as well as the use of haploidentical natural killer (NK) cells can induce remission in patients with lymphoma and leukemia. Although the use of CAR T cells has been established, this approach is currently limited for wider use by the risk of severe adverse events, including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome.
View Article and Find Full Text PDFThe antimicrobial protein RNase 7 directly restricts herpes simplex virus infection of human keratinocytes.
J Med Virol
October 2024
Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
Article Synopsis
- About 22% of patients with moderate to severe atopic dermatitis have experienced eczema herpeticum, an infection primarily caused by the herpes simplex virus type 1 (HSV-1), potentially due to reduced antimicrobial peptide activity.
- This study found that the antimicrobial protein RNase 7 can limit HSV-1 infection in human skin cells (keratinocytes) by inhibiting gene expression and viral genome replication without relying on added DNA for stimulation.
- RNase 7 acts on intracellular processes of infection rather than affecting how the virus binds to cells, suggesting that its reduced activity in atopic dermatitis may increase the risk of developing eczema herpeticum.
Article Synopsis
- Long-acting antiretroviral agents like Lenacapavir (LEN) offer a new option for HIV prevention, potentially replacing daily oral medications.
- In studies with macaques, a single high dose of LEN effectively protected against a rectal challenge with the simian-human immunodeficiency virus (SHIV), maintaining drug levels that corresponded to clinical efficacy targets.
- Most macaques treated with LEN remained uninfected and showed no signs of drug resistance, suggesting LEN's potential for effective HIV prophylaxis in humans.
Mechanisms and strategies for safe chimeric antigen receptor T-cell activity control.
Int J Cancer
November 2023
Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Ludwig-Maximilians-Universität München (LMU), Munich, Germany.
The clinical application of chimeric antigen receptor (CAR) T-cell therapy has rapidly changed the treatment options for terminally ill patients with defined blood-borne cancer types. However, CAR T-cell therapy can lead to severe therapy-associated toxicities including CAR-related hematotoxicity, ON-target OFF-tumor toxicity, cytokine release syndrome (CRS) or immune effector cell-associated neurotoxicity syndrome (ICANS). Just as CAR T-cell therapy has evolved regarding receptor design, gene transfer systems and production protocols, the management of side effects has also improved.
View Article and Find Full Text PDFFrom structure to function - Ligand recognition by myeloid C-type lectin receptors.
Comput Struct Biotechnol J
October 2022
Institute for Immunology, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.
The relevance of protein-glycan interactions in immunity has long been underestimated. Yet, the immune system possesses numerous classes of glycan-binding proteins, so-called lectins. Of specific interest is the group of myeloid C-type lectin receptors (CLRs) as they are mainly expressed by myeloid cells and play an important role in the initiation of an immune response.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!